For women with breast cancer, rates of locoregional recurrence after skin- and nipple-sparing mastectomy are low (approximately 5%) and often exceeded by those for distant metastases.1,2 As a result, these contemporary mastectomy techniques in conjunction with breast reconstruction have become widely adopted owing to improved patient-reported outcomes related to cosmesis and quality of life.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Fayanju OM, Hollenbeck ST, Greenup RA. Oncologic Outcomes After Neoadjuvant Chemotherapy and Postmastectomy Breast Reconstruction. JAMA Surg. Published online October 14, 2020. doi:10.1001/jamasurg.2020.4138
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: